Ron Baron

Ron Baron

Last Update: 05-16-2016

Number of Stocks: 296
Number of New Stocks: 23

Total Value: $18,898 Mil
Q/Q Turnover: 5%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Ron Baron' s Profile & Performance

Profile

Ron Baron is the founder of Baron Capital Management. He is Co-Portfolio Manager of Baron Asset Fund and remains Portfolio Manager of the Growth and Partners Funds. Baron graduated from Bucknell University with a B.A. in Chemistry, and later attended George Washington University Law School in the evenings.

Web Page:http://www.baronfunds.com/

Investing Philosophy

Ron Baron invests primarily in small and mid-size growth companies. He likes companies with open-ended growth opportunities and defensible niches. He applies a bottom-up company research, invests for the long-term, and tries to purchase companies at what he believes are attractive prices. He invests in growth companies using a value-oriented purchase discipline. Baron ignores short-term market fluctuations when he believes the fundamental reasons for purchasing a company have not changed. He holds investments for longer than five years on average.

Total Holding History

Performance of Baron Partners Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
2015-2.711.19-3.9
201410.2613.69-3.4
201347.6332.3915.2
3-Year Cumulative58.4 (16.6%/year)52.3 (15.1%/year)6.1 (1.5%/year)
201216.4160.4
2011-5.742.11-7.8
5-Year Cumulative73.8 (11.7%/year)80.4 (12.5%/year)-6.6 (-0.8%/year)
201031.5215.0616.5
200928.226.461.7
2008-46.67-37-9.7
200711.345.495.9
200621.5515.795.8
10-Year Cumulative111.4 (7.8%/year)102 (7.3%/year)9.4 (0.5%/year)
200514.374.919.5
200442.3510.8831.5
200334.9528.686.3
2002-18.07-22.14.0
2001-15.71-11.89-3.8
15-Year Cumulative220.8 (8.1%/year)107.5 (5%/year)113.3 (3.1%/year)
20004.82-9.113.9
199918.4221.04-2.6
199811.6828.58-16.9
199749.8833.3616.5
199616.1322.96-6.8
20-Year Cumulative674.1 (10.8%/year)381.4 (8.2%/year)292.7 (2.6%/year)
199536.9437.58-0.6
19944.761.323.4
199328.7810.0818.7
199216.837.629.2

Top Ranked Articles

Tallgrass Energy Partners Insider Adds to Stake Company's CEO purchases 5,300 shares
David Dehaemers Jr. (Insider Trades), CEO and president of Tallgrass Energy Partners LP (TEP), purchased 5,300 shares of the company on May 26. The price per share was $45.11 for a total transaction of $239,083. Read more...
Baron Funds Comments on Facebook Guru stock highlight
Shares of Facebook, Inc. (NASDAQ:FB), the world’s largest social network, rose in the first quarter, driven by improving consumer engagement and monetization. Facebook is the largest beneficiary of the shift in consumer engagement to mobile. Facebook is using its leadership position to provide global advertisers targeted marketing capabilities at scale. Facebook is in the early stages of monetizing online video and Instagram, which are starting to contribute to incremental revenue growth. WhatsApp and Oculus provide additional avenues for growth opportunities. Read more...
Baron Funds Comments on Brookfield Asset Management Guru stock highlight
Shares of Brookfield Asset Management, Inc. (NYSE:BAM) rose in the first quarter due to strong conditions in most of its business segments. The company is a global alternative asset manager with approximately $200 billion in assets under management, with a focus on real estate property, infrastructure, renewable energy, and private equity. A high quality portfolio, stable cash flows and attractive growth opportunities, global scale, a quality balance sheet, and an excellent management team with significant insider ownership support our favorable view. Read more...
Baron Funds Comments on Equinix Inc. Guru stock highlight
Equinix, Inc., (NASDAQ:EQIX) an operator of carrier-neutral data centers, continued to make progress on several fronts: 1) the closing of its Telecity acquisition in Europe, 2) a strong finish to 2015 with organic growth beating analyst expectations, and 3) maintaining financial flexibility and a strong balance sheet in an uncertain market. In addition, supply/demand in the data center space is favorable and price accommodative with consolidation capping supply and cloud and outsourcing lifting demand. All of those contributed to an increase in the stock price in the first quarter. Read more...
Baron Funds Comments on YUM! Brands Guru stock highlight
Shares of YUM! Brands, Inc., (NYSE:YUM) a global operator and franchisor of the Pizza Hut, Taco Bell, and KFC restaurant brands, were up in the first quarter as the date of its spin-out of its struggling Chinese business approaches. News that private equity funds are considering investing in YUM! China lent support to estimates around the value of that business. We believe the ex-China operation is a high-quality, capital-efficient franchising business with continued growth potential and the Chinese business offers some optionality for a turn-around. Read more...
» More Ron Baron Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Tallgrass Energy Partners Insider Adds to Stake Company's CEO purchases 5,300 shares Ron Baron,Jim Simons - Tallgrass Energy Partners Insider Adds To Stake
David Dehaemers Jr. (Insider Trades), CEO and president of Tallgrass Energy Partners LP (TEP), purchased 5,300 shares of the company on May 26. The price per share was $45.11 for a total transaction of $239,083. More...

DAVID DEHAEMERS JR, INSIDER TRADES, TALLGRASS ENERGY PARTNERS LP


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Baron Funds Comments on Bristol-Myers Squibb Guru stock highlight
After watching and following Bristol-Myers Squibb (NYSE:BMY) for the better part of the last three years we used the weakness in the stock created by the sell-off in the biotech sector to finally initiate a small to medium size position. Bristol specializes in small molecule drugs known as biologics, which are harder for the generic drug companies to replicate, and we are particularly excited about its lead immuno-oncology asset, Opdivo which has shown incredible promise in the treatment of lung cancer, while growing 10-20% month over month since its approval in 2015. Based on our belief in the effectiveness of the PD-1 class drugs, we think there is a high likelihood that Bristol will be able to gain approvals and expand the usage of Opdivo in other types of cancers (melanoma, renal, head and neck, hodgkin’s lymphoma, etc.) and could potentially change the paradigm of cancer’s treatment worldwide. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Illumina Inc. Guru stock highlight
Shares of Illumina, Inc. (NASDAQ:ILMN) detracted from performance in the first quarter. Illumina is the leading provider of DNA sequencing technology to academic and commercial laboratories. Although fourth quarter financial results were solid, management tempered expectations for the first quarter HiSeq X and benchtop instrument sales. We continue to believe Illumina has a long runway for growth, driven by increasing adoption of DNA sequencing in clinical markets such as cancer screening, diagnosis, and treatment. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Regeneron Pharmaceuticals Guru stock highlight
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) fell in the first quarter as a result of the significant sell-off in the biotech/pharma space and a miss on the top and bottom lines versus the expected fourth quarter results. 2016 guidance for Eylea (its lead ophthalmology asset) was sharply down from 2015. Launch of its new cardiovascular drug, Praluent, has been slow, and it lost a court case involving the drug. We have trimmed our position but decided that Regeneron deserved benefit of the doubt. Given Sanofi’s 22% ownership and its reliance on company for R&D productivity, we believe Regeneron enjoys a privileged position in the biotech universe. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Alexion Pharmaceuticals Guru stock highlight
Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) fell in the first quarter as a result of the significant correction in the biotech/pharma space. Alexion develops treatments for rare diseases. Its high foreign exchange exposure and high multiple also pressured the stock. Overall, we believe there have been no significant changes to the fundamentals of Alexion’s investment thesis (innovative, exceptionally well-managed company with unique assets and pricing power) and we retain conviction. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Baron Funds Comments on Alexion Pharmaceuticals Guru stock highlight
Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) fell in the first quarter as a result of the significant correction in the biotech/pharma space. Alexion develops treatments for rare diseases. Its high foreign exchange exposure and high More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on LinkedIn Corp Guru stock highlight
LinkedIn Corp. (NYSE:LNKD) is the world’s largest online professional network. It has three business segments: Hiring Solutions, Marketing Solutions, and Premium Subscriptions, each serving different customers. Despite strong 4Q15 results, shares were down in the first quarter due to a weak 2016 outlook. After several quarters of inconsistent results, we believe management is finding it increasingly difficult to manage the complexity of three businesses. We exited the position. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Amazon.com Guru stock highlight
Shares of Amazon.com, Inc. (NASDAQ:AMZN), the world’s largest retailer, declined in the first quarter despite reporting strong revenue growth likely due to retail margins being lower than anticipated. Amazon has responded by instituting substantial fulfillment and supply chain fee increases for merchants on the platform. We estimate that these fee increases should start to alleviate the recent pressure on retail margins in the upcoming quarters. Amazon’s other major business segment, Amazon Web Services (AWS) continues to gain traction with enterprise customers, and over time, we expect AWS to be the larger contributor to value creation for the company. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Baron Funds Comments on ASML Holding N.V. Guru stock highlight
ASML Holding N.V. (NASDAQ:ASML) is a unique, near-monopoly company in semiconductor manufacturing. ASML’s equipment, which prints the tiniest circuits for chips, is used by nearly every manufacturer. Over the next few years, ASML plans to roll out equipment that can print circuits smaller than any other company. We believe over time its equipment will become indispensable and earnings will grow rapidly. Shares were up in the first quarter after management stated on its earnings call that it expects equipment orders to accelerate in the second half of 2016. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Baron Funds Comments on YUM! Brands Guru stock highlight
Shares of YUM! Brands, Inc., (NYSE:YUM) a global operator and franchisor of the Pizza Hut, Taco Bell, and KFC restaurant brands, were up in the first quarter as the date of its spin-out of its struggling Chinese business approaches. News that private equity funds are considering investing in YUM! China lent support to estimates around the value of that business. We believe the ex-China operation is a high-quality, capital-efficient franchising business with continued growth potential and the Chinese business offers some optionality for a turn-around. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Equinix Inc. Guru stock highlight
Equinix, Inc., (NASDAQ:EQIX) an operator of carrier-neutral data centers, continued to make progress on several fronts: 1) the closing of its Telecity acquisition in Europe, 2) a strong finish to 2015 with organic growth beating analyst expectations, and 3) maintaining financial flexibility and a strong balance sheet in an uncertain market. In addition, supply/demand in the data center space is favorable and price accommodative with consolidation capping supply and cloud and outsourcing lifting demand. All of those contributed to an increase in the stock price in the first quarter. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Baron Funds Comments on Brookfield Asset Management Guru stock highlight
Shares of Brookfield Asset Management, Inc. (NYSE:BAM) rose in the first quarter due to strong conditions in most of its business segments. The company is a global alternative asset manager with approximately $200 billion in assets under management, with a focus on real estate property, infrastructure, renewable energy, and private equity. A high quality portfolio, stable cash flows and attractive growth opportunities, global scale, a quality balance sheet, and an excellent management team with significant insider ownership support our favorable view. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Facebook Guru stock highlight
Shares of Facebook, Inc. (NASDAQ:FB), the world’s largest social network, rose in the first quarter, driven by improving consumer engagement and monetization. Facebook is the largest beneficiary of the shift in consumer engagement to mobile. Facebook is using its leadership position to provide global advertisers targeted marketing capabilities at scale. Facebook is in the early stages of monetizing online video and Instagram, which are starting to contribute to incremental revenue growth. WhatsApp and Oculus provide additional avenues for growth opportunities. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ron Baron Exits Towers Watson Company is trading above intrinsic value and has been issuing new debt over the previous 9 years Ron Baron,Mario Gabelli,Chuck Royce,Pioneer Invest - Ron Baron Exits Towers Watson
Guru Ron Baron (Trades, Portfolio) sold his 762,284-share stake in Towers Watson & Co. (NASDAQ:TW) in the first quarter. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Glaukos Corporation Guru stock highlight
Shares of Glaukos Corporation (NYSE:GKOS) declined in the first quarter as a result of the massive correction in the biotech/pharma space. Glaukos, which manufactures stents to relieve glaucoma pressure, expects 26% to 30% growth in 2016, which we think will drive revenue to $90 millin to $93 million. While major label expansion to deliver Glaukos’ iStents without cataract surgery (current FDA approval) is still some years away, we retain conviction because of the growth opportunity presented by the rising incidence of glaucoma as a result of the aging U.S. population. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Baron Funds Comments on Pacira Pharmaceuticals Inc. Guru stock highlight
Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) is a specialty pharmaceutical company that sells a drug for local surgical analgesia (an anesthetic) called EXPAREL. At the end of the third quarter of 2015, Pacira received a favorable resolution of certain FDA issues, and we re-established our investment at the lower levels caused by the prior regulatory uncertainty. In our opinion, shares were down in the first quarter due to the general negative industry dynamics around pharmaceutical companies. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on TerraForm Global Inc. Guru stock highlight
Shares of TerraForm Global Inc. (NASDAQ:GLBL), an owner of renewable energy power plants in emerging markets, fell during the quarter due to uncertainty related to the implications of a potential bankruptcy of parent company SunEdison (SUNEQ). In addition, TerraForm Global was unable to execute on transactions to create its formation portfolio. These factors make the company difficult to value, and the stock sold off as a result. We continue to hold the stock as we believe the company is solvent and has enough liquidity to continue. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Just Eat PLC Guru stock highlight
Shares of Just Eat PLC (LSE:JE.), the leading online food takeout marketplace in Europe, Latin America, and Canada, were down in the first quarter despite reporting second half of 2015 results that beat consensus analyst expectations. Potential entry by Uber into restaurant delivery in the U.K., Just Eat’s largest market, is driving heightened competitive concerns. We believe Just Eat competes in a different market segment from Uber and other delivery-oriented companies. We think Just Eat is the leader in a winner-take-most/all business that will not be meaningfully disrupted by new competitors. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Baron Funds Comments on Facebook Inc. Guru stock highlight
Shares of Facebook Inc. (NASDAQ:FB), the world’s largest social network, rose in the first quarter, driven by improving consumer engagement and monetization. Facebook is the largest beneficiary of the shift in consumer engagement to mobile. Facebook is using its leadership position to provide global advertisers targeted marketing capabilities at scale. Facebook is in the early stages of monetizing online video and Instagram, which are starting to contribute to incremental revenue growth. WhatsApp and Oculus provide additional avenues for growth opportunities. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Baron Funds Comments on Mellanox Technologies Guru stock highlight
Mellanox Technologies (NASDAQ:MLNX) supplies semiconductor-based interconnect solutions and services. Strong fourth quarter results re-instilled investor confidence in Mellanox’s ability to grow profitably. In addition, the completion of its EZchip acquisition and adjusted guidance laid out a strong financial case for this combination. We view Mellanox’s Ethernet business as a significant open-ended opportunity. We expect Mellanox to be a high-end market leader and protect its high margin business model with strong innovation and product leadership. More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK